Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

2022 National Partner Society Abstract Achievement Awards

November 18, 2022

The National Partner Society Abstract Achievement Awards are awarded to an international hematologist, who must be a member of the supporting organization and resident of the respective country, to help advance knowledge and inspire continued professional development in hematology. The awardees can be undergraduate students, medical students, graduate students, resident physicians, or postdoctoral MD or PhD fellows.

ASH-Haematology Society of Australia and New Zealand (HSANZ) Abstract Achievement Awards

Chanukya Colonne, BSc (Adv), MBBS, PhD
University of Sydney
Abstract 287: A Putative Erythroid Synapse Linking Developing Erythroblasts and Macrophages in Erythroblastic Islands (101. Red Cells and Erythropoiesis, Excluding Iron I)
Saturday, December 10, 4:00 p.m.-5:30 p.m., Ernest N. Morial Convention Center, Room 391-392

ASH-Japanese Society of Hematology (JSH) Abstract Achievement Awards

Yuta Yamada, MD
The University of Tokyo
Abstract 921:
Mlkl Mediates Age-Related Attrition of Hematopoietic Stem Cells and Ineffective Hematopoiesis in Myelodysplastic Syndrome (501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Disease and Aging)
Monday, December 12, 4:30 p.m.-6:00 p.m., Ernest N. Morial Convention Center, Room 393-396

Takao Yogo, MD
The University of Tokyo
Abstract 922: Activated CMPs Act in Concert with the Spleen and Accelerate Hematopoietic Inflation after Transplantation (501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Disease and Aging)
Monday, December 12, 4:30 p.m.-6:00 p.m., Ernest N. Morial Convention Center, Room 393-396

Shinpei Harada
Hokkaido University
Abstract 974: Intercellular Mitochondrial Transfer Enhances Metabolic Fitness and Anti-Tumor Effects of CAR T Cells (703. Cellular Immunotherapies: Basic and Translational III)
Monday, December 12, 4:30 p.m.-6:00 p.m., Ernest N. Morial Convention Center, La Nouvelle Orleans Ballroom C

ASH-Society Italiana di Ematologia (SIE) Abstract Achievement Awards

Laura Notarfranchi, MD
University of Parma
Abstract 865: Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow (652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: New Approaches to MRD Assessment)
Monday, December 12, 2:45 p.m.-4:15 p.m., Ernest N. Morial Convention Center, Great Hall B/C

Giovanni Marconi, MD
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori “Dino Amadori”
Abstract 710: Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia (616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Frontline and Maintenance)
Monday, December 12, 10:30 a.m.-12:00 noon, Ernest N. Morial Convention Center, Room 275-277

ASH-British Society of Hematology (BSH) Abstract Achievement Award

Niels Asger Jakobsen, BMBCh, MRCP
University of Oxford
Abstract 925:
Single-Cell Analysis of Human Clonal Hematopoiesis Identifies Distinct Impact of DNMT3A and TET2 mutations on Hematopoietic Differentiation (503. Clonal Hematopoiesis, Aging and Inflammation: Insights from Human Cohorts And Biosamples)
Monday, December 12, 4:30 p.m.-6:00 p.m., Ernest N. Morial Convention Center, Room 252-254

Anna Santarsieri, MBBS
Cambridge University Hospitals NHS Foundation Trust
Abstract 732: Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy (624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Hodgkin Lymphoma: Retrospective Analyses and Prospective Trials)
Monday, December 12, 10:30 a.m.-12:00 noon, Ernest N. Morial Convention Center, Room 265-268

Shuchi Agrawal Singh, PhD
Cambridge Institute for Medical Research, Cambridge Biomedical Campus
Abstract 295: HOXA9 Nucleates a Repressive Chromatin Complex with Nuclear Matrix-Associated Protein- Safb to Maintain Acute Myeloid Leukemia (602. Myeloid Oncogenesis: Basic: Chromatin Organization and Metabolism)
Saturday, December 10, 4:00 p.m.-5:30 p.m., Ernest N. Morial Convention Center, Room 293-294

 

 

Close Modal

or Create an Account

Close Modal
Close Modal